Quality statement 4 (placeholder): Ongoing training in adrenaline auto‑injector use
A placeholder statement is an area of care that has been prioritised by the Quality Standards Advisory Committee but for which no source guidance is currently available. A placeholder statement indicates the need for evidence‑based guidance to be developed in this area.
Recurrence of an anaphylactic reaction can occur a long time after an adrenaline auto‑injector is first prescribed and after a person, and their families or carers, are shown how to use the device. People who have been prescribed an adrenaline auto‑injector following an anaphylactic reaction are more likely to be able to self‑manage anaphylactic reactions if they are provided with ongoing training on how and when to use their adrenaline auto‑injector.